FDA removes ‘black box’ warning label on hormone replacement therapy for menopause
(NEW YORK) -- The Food and Drug Administration said Monday it will remove the "black box" warning from hormone replacement therapy (HRT) products for menopause.The change comes after two studies in the early 2000s claimed that there were major risks associated with HRT, including... Read More.
